Profil
Eli Zangvil is currently the Chief Executive Officer & Director at Stromal Therapeutics AG.
Previously, he held positions as a Director at Evogene Ltd., Vice President-Business Development at Compugen Ltd., and Chief Operating Officer at UltraShape, Inc. He has a graduate degree from Tel-Aviv University and a doctorate degree from The Hebrew University of Jerusalem.
Postes actifs de Eli Zangvil
| Sociétés | Poste | Début |
|---|---|---|
Stromal Therapeutics AG
Stromal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as an biotech company that develops generation immunotherapies | Directeur Général | 01/01/2023 |
Anciens postes connus de Eli Zangvil
| Sociétés | Poste | Fin |
|---|---|---|
| EVOGENE LTD. | Directeur/Membre du Conseil | 01/01/2011 |
| COMPUGEN LTD. | Corporate Officer/Principal | - |
UltraShape, Inc.
UltraShape, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets non-invasive technologies | Directeur des opérations | - |
Formation de Eli Zangvil
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
UltraShape, Inc.
UltraShape, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets non-invasive technologies | Commercial Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evogene Ltd.
Evogene Ltd. BiotechnologyHealth Technology Operates as computational biology company, which focuses on product discovery and development | Health Technology |
Stromal Therapeutics AG
Stromal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as an biotech company that develops generation immunotherapies | Commercial Services |
















